The HBA1 gene thalassemia alpha genetic test is a specialized diagnostic procedure designed to detect mutations in the HBA1 gene, which are responsible for alpha thalassemia, a genetic blood disorder. This condition affects the production of hemoglobin, the protein in red blood cells that carries oxygen throughout the body. Mutations in the HBA1 gene can lead to various forms of alpha thalassemia, ranging from silent carriers with no apparent symptoms to more severe forms that can cause significant health issues, including anemia and complications in fetal development.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient's DNA to identify mutations in the HBA1 gene. This information is crucial for diagnosing the specific type of alpha thalassemia, understanding the risk of transmitting the condition to offspring, and determining appropriate management and treatment plans for affected individuals.
The cost of the HBA1 gene thalassemia alpha genetic test at DNA Labs UAE is 4400 AED. This investment in health allows individuals and families to gain valuable insights into their genetic makeup, facilitating informed decisions about their healthcare and future family planning.
The HBA2 gene thalassemia alpha genetic test is a specific diagnostic tool designed to detect mutations in the HBA2 gene, which is one of the genes responsible for the production of the alpha globin component of hemoglobin. Mutations or deletions in this gene can lead to alpha thalassemia, a blood disorder that reduces the production of normal hemoglobin, the protein in red blood cells that carries oxygen to cells throughout the body. This condition can range from mild to severe, with the most severe form being fatal before or shortly after birth.
DNA Labs UAE offers this crucial genetic test for individuals who may be carriers or at risk of having children with alpha thalassemia. The test, priced at 4400 AED, involves analyzing the patient's DNA to look for specific mutations in the HBA2 gene. It is particularly recommended for those with a family history of thalassemia or individuals of ethnic backgrounds with a higher prevalence of the disease, such as people of Mediterranean, Middle Eastern, South Asian, and African ancestries.
By identifying carriers of the HBA2 gene mutations, the test plays a vital role in genetic counseling, family planning, and in some cases, guiding treatment decisions for those affected by the condition. It provides valuable information that can help prevent the transmission of the disease to future generations and prepare for the medical management of affected individuals.
GPI Gene Hemolytic Anemia Nonspherocytic due to Glucose Phosphate Isomerase Deficiency is a rare genetic disorder affecting the red blood cells. This condition is characterized by the body's inability to properly produce glucose phosphate isomerase, an enzyme essential for the glycolytic pathway, leading to nonspherocytic hemolytic anemia. Symptoms can vary from mild to severe and may include fatigue, jaundice, an enlarged spleen, and increased susceptibility to infections.
To diagnose this condition, a genetic test targeting the GPI gene can be performed. This test identifies mutations in the GPI gene that are responsible for the enzyme deficiency. DNA Labs UAE offers this specific genetic testing service for individuals suspected of having this rare disorder. The cost of the test is 4400 AED. This comprehensive testing can be crucial for accurate diagnosis, allowing for appropriate management and treatment strategies to be implemented for those affected by this condition.
The F9 Gene Hemophilia B Genetic Test is a specialized diagnostic procedure designed to identify mutations in the F9 gene, which is responsible for Hemophilia B, also known as Christmas disease. This condition is a genetic disorder that leads to impaired blood clotting, resulting in prolonged bleeding following injury or surgery, and can cause spontaneous bleeding episodes. The test is crucial for the accurate diagnosis of Hemophilia B, enabling healthcare providers to tailor treatment plans and manage the condition effectively.
Conducted at DNA Labs UAE, a leading facility known for its advanced genetic testing services, the test involves analyzing the patient's DNA sample, usually obtained from a blood draw, to look for specific genetic alterations in the F9 gene that are indicative of Hemophilia B. The process is highly sophisticated, ensuring reliable and accurate results that are essential for the appropriate management of the disorder.
The cost of the F9 Gene Hemophilia B Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the presence of the genetic mutations associated with Hemophilia B. Given the complexity of genetic testing and the specialized technology and expertise required, the cost reflects the value of obtaining a definitive diagnosis, which is crucial for affected individuals and their families to understand the condition and make informed decisions about treatment and management.
The HBG2 gene hereditary persistence of fetal hemoglobin (HPFH) genetic test is a specialized diagnostic procedure aimed at detecting mutations in the HBG2 gene. These mutations are associated with the hereditary persistence of fetal hemoglobin (HPFH), a condition where individuals continue to produce fetal hemoglobin (HbF) at elevated levels into adulthood. Normally, the production of HbF, which has a high affinity for oxygen, ceases after birth, and its expression is replaced by adult hemoglobin. However, in HPFH, the elevated levels of HbF can ameliorate symptoms of hemoglobinopathies like beta-thalassemia and sickle cell disease, leading to a milder clinical presentation.
The test involves analyzing the patient's DNA, extracted from a blood sample, to identify specific genetic variations or mutations in the HBG2 gene that are known to cause HPFH. This genetic testing is crucial for individuals with a family history of HPFH or related hemoglobin disorders, as it can provide valuable information for disease management and genetic counseling.
Performed at DNA Labs UAE, a leading provider of genetic testing services in the region, the HBG2 gene HPFH genetic test is priced at 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced geneticists and laboratory technicians, ensuring high-quality and accurate testing results. This test is an essential tool for the early diagnosis and management of HPFH, helping affected individuals and their families make informed health and lifestyle decisions.
The "LARS2 Gene Hydrops Lactic Acidosis and Sideroblastic Anemia Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the LARS2 gene. This gene is crucial for mitochondrial protein synthesis and its mutations are associated with a rare but severe condition that combines features of hydrops, lactic acidosis, and sideroblastic anemia. These symptoms are indicative of mitochondrial dysfunction, which can lead to a wide range of clinical manifestations, including metabolic disturbances and hematologic abnormalities.
The test, priced at 4400 AED, involves collecting a DNA sample from the patient, typically through a blood draw. The sample is then analyzed in the laboratory using advanced genetic sequencing technologies to detect mutations in the LARS2 gene. This test is particularly valuable for individuals presenting with symptoms suggestive of the condition, or for families with a history of mitochondrial or metabolic disorders, providing crucial information for diagnosis, management, and genetic counseling.
DNA Labs UAE is equipped with state-of-the-art facilities and staffed by experienced geneticists and laboratory technicians, ensuring high-quality testing and reliable results. The test results can guide healthcare providers in tailoring a comprehensive management plan for affected individuals, potentially including treatments to manage symptoms, dietary recommendations, and other supportive care measures.
The "CBLIF Gene Intrinsic Factor Deficiency Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the CBLIF gene, which can lead to intrinsic factor deficiency. This condition is critical as intrinsic factor is essential for the absorption of vitamin B12, and its deficiency can result in pernicious anemia and other serious health issues, including neurological damage. The test is particularly valuable for individuals experiencing symptoms related to vitamin B12 deficiency or those with a family history of pernicious anemia.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis of the CBLIF gene to pinpoint any genetic variations that might affect the production or function of intrinsic factor. This is crucial for early detection and management of the condition, enabling healthcare providers to tailor treatment plans that can mitigate symptoms and prevent progression.
The cost of the test is set at 4400 AED, reflecting the intricate technologies and expertise involved in genetic analysis. While the price may seem steep, the insights gained from this test can be invaluable in guiding effective treatment strategies and improving patient outcomes. Individuals considering this test are encouraged to consult with their healthcare provider to understand its benefits and implications fully.
The TMPRSS6 Gene Iron-Refractory Iron Deficiency Anemia Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the TMPRSS6 gene. This gene plays a crucial role in the regulation of iron metabolism in the body. Mutations in the TMPRSS6 gene can lead to Iron-Refractory Iron Deficiency Anemia (IRIDA), a rare and inherited form of anemia that does not respond to oral iron supplements and only partially responds to intravenous iron therapy.
The test is aimed at individuals who exhibit symptoms of iron deficiency anemia that does not improve with standard iron supplementation, suggesting the possibility of an underlying genetic condition like IRIDA. By analyzing the patient's DNA, the test identifies specific mutations in the TMPRSS6 gene that are responsible for the disorder, thereby facilitating a precise diagnosis.
Conducted at DNA Labs UAE, a facility known for its advanced genetic testing services, the test offers a critical tool for healthcare providers in the management of patients with unexplained iron deficiency anemia. The cost of the test is 4400 AED, reflecting the comprehensive analysis and the specialized technology employed in detecting the genetic mutations associated with this condition.
By confirming a diagnosis of IRIDA, the TMPRSS6 Gene Iron-Refractory Iron Deficiency Anemia Genetic Test enables targeted treatment approaches that can significantly improve patient outcomes. This test represents an important step forward in the personalized treatment of iron deficiency anemia, offering hope to those affected by this challenging condition.
The "TERT Gene Leukemia Acute Myeloid Form Susceptible Due to TERT Germline Mutation Genetic Test" is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify individuals who are at an increased risk of developing acute myeloid leukemia (AML) due to mutations in the TERT gene. The TERT gene plays a crucial role in the maintenance of telomeres, which are protective caps at the ends of chromosomes. Mutations in this gene can lead to telomere dysfunction, contributing to the development of various cancers, including AML.
This test is particularly important for individuals with a family history of leukemia or other telomere-related disorders, as it can help in early detection and management of the condition. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test ensures accuracy and confidentiality. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to analyze the genetic material for TERT mutations accurately.
By opting for this test, individuals can gain valuable insights into their genetic predisposition to AML, enabling them to take proactive measures in consultation with healthcare professionals.
The FERMT3 Gene Leukocyte Adhesion Deficiency Type 3 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the FERMT3 gene that are responsible for Leukocyte Adhesion Deficiency Type 3 (LAD3). This condition is a rare, autosomal recessive immune disorder characterized by the body's inability to properly control infection, leading to severe, recurrent infections and delayed wound healing. The test is crucial for early diagnosis and management of the condition, enabling targeted treatments and interventions that can significantly improve the quality of life for affected individuals. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately analyze and interpret the genetic data. Conducted in the state-of-the-art facilities of DNA Labs UAE, this genetic test represents a vital resource for families at risk of LAD3, providing them with essential information for making informed health decisions.
